HCA Healthcare, Inc. $HCA Shares Bought by Captrust Financial Advisors

Captrust Financial Advisors grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.8% during the third quarter, Holdings Channel.com reports. The fund owned 305,705 shares of the company’s stock after acquiring an additional 2,570 shares during the period. Captrust Financial Advisors’ holdings in HCA Healthcare were worth $130,291,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter valued at $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of HCA Healthcare by 49.9% in the second quarter. SG Americas Securities LLC now owns 10,787 shares of the company’s stock valued at $4,132,000 after purchasing an additional 3,593 shares in the last quarter. Finally, Cetera Investment Advisers lifted its holdings in HCA Healthcare by 0.7% during the 2nd quarter. Cetera Investment Advisers now owns 32,379 shares of the company’s stock worth $12,405,000 after buying an additional 211 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HCA shares. Mizuho upped their price objective on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Jefferies Financial Group boosted their target price on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Wall Street Zen lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Robert W. Baird upped their target price on shares of HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Finally, UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Stock Performance

HCA opened at $510.34 on Wednesday. The business’s 50-day simple moving average is $508.54 and its 200-day simple moving average is $472.06. The company has a market cap of $114.10 billion, a P/E ratio of 17.98, a PEG ratio of 1.61 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $314.43 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is presently 10.15%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.